Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/24493

Title:	Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report
Authors:	Uludağ Üniversitesi/Tıp Fakültesi. Avcı, Nilüfer Kanat, Özkan Gökgöz, Şehsuvar Tolunay, Şahsine Topal, Uğur Çubukçu, Erdem Ölmez, Fatih AAI-1612-2021
Keywords:	Oncology
Issue Date:	Sep-2012
Publisher:	Elsevier
Citation:	Avcı, N. vd. (2012). "Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report". Annals of Oncology, 23, Supplement 9, 129-129.
Description:	Bu çalışma, 28 Eylül-02 Ekim 2012 tarihleri arasında Vienna[Austria]’da düzenlenen 37. Congress of the European-Society-for-Medical-Oncology (ESMO)’da bildiri olarak sunulmuştur.
URI:	https://www.sciencedirect.com/journal/annals-of-oncology/vol/23/suppl/S9 http://hdl.handle.net/11452/24493
ISSN:	0923-7534
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI